Structured evidence table for Vitamin D Immune Function Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Vitamin D Immune Function Randomized Trial | Results We found no significant difference in GVHD occurrence and levels of retinoids between the intervention and control groups at either of the two time points. | 2 | Iversen PO (2026) | Plasma Levels of Retinoids and Carotenoids in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Given Extracorporeal Photopheresis to Prevent Graft-Versus-Host Disease-Analyses From a Randomized Trial. |
| Vitamin D Immune Function Randomized Trial | Conclusion Whether routine vitamin A supplementation is warranted for GVHD prevention, needs further study. | 2 | Iversen PO (2026) | Plasma Levels of Retinoids and Carotenoids in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Given Extracorporeal Photopheresis to Prevent Graft-Versus-Host Disease-Analyses From a Randomized Trial. |
| Vitamin D Immune Function Randomized Trial | Introduction Whether retinoids and carotenoids impact on graft-versus-host disease (GVHD) following allogeneic stem cell transplantation (ASCT) is unknown. | 2 | Iversen PO (2026) | Plasma Levels of Retinoids and Carotenoids in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Given Extracorporeal Photopheresis to Prevent Graft-Versus-Host Disease-Analyses From a Randomized Trial. |
| Vitamin D Immune Function Randomized Trial | Methods We conducted a 1:1 randomized controlled trial with extracorporeal photopheresis for GVHD-prophylaxis as the intervention. | 2 | Iversen PO (2026) | Plasma Levels of Retinoids and Carotenoids in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Given Extracorporeal Photopheresis to Prevent Graft-Versus-Host Disease-Analyses From a Randomized Trial. |
| Vitamin D Immune Function Randomized Trial | Studies on vitamin D have increased tremendously since the vitamin D receptor VDR has been identified in the whole immune cell population, including macrophages, dendritic cells (DCs), T cells, and B cells []. | 3 | Shende Sandesh (2026) | Vitamin D as an Immuno-Endocrine Modulator: Discovering Its Role in Autoimmune Disorders and Host Defense Mechanisms |
| Vitamin D Immune Function Randomized Trial | 11 2 12 13 14 Vitamin D was historically confined to skeletal biology, primarily associated with calcium–phosphate homeostasis and the prevention of rickets, osteomalacia, and osteoporosis []. | 3 | Shende Sandesh (2026) | Vitamin D as an Immuno-Endocrine Modulator: Discovering Its Role in Autoimmune Disorders and Host Defense Mechanisms |
| Vitamin D Immune Function Randomized Trial | Accumulating evidence indicates that hypovitaminosis D is common in autoimmune disorders such as multiple sclerosis (MS), type 1 diabetes mellitus (T1DM), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE), as well as in infectious diseases, including tuberculosis and acute respiratory tract infections []. | 3 | Shende Sandesh (2026) | Vitamin D as an Immuno-Endocrine Modulator: Discovering Its Role in Autoimmune Disorders and Host Defense Mechanisms |
| Vitamin D Immune Function Randomized Trial | 1 2 3 4 5 6 7 8 9 10 2 3 Vitamin D was historically confined to skeletal biology. | 3 | Shende Sandesh (2026) | Vitamin D as an Immuno-Endocrine Modulator: Discovering Its Role in Autoimmune Disorders and Host Defense Mechanisms |
Source documents